Serine 312 phosphorylation is dispensable for wild-type p53 functions in vivo

被引:0
|
作者
M K Lee
W M Tong
Z Q Wang
K Sabapathy
机构
[1] Laboratory of Molecular Carcinogenesis,Division of Cellular & Molecular Research
[2] Humphrey Oei Institute of Cancer Research,Department of Biochemistry
[3] National Cancer Centre,undefined
[4] 11,undefined
[5] Hospital Drive,undefined
[6] Singapore 169610,undefined
[7] Singapore,undefined
[8] Institute of Basic Medical Sciences School of Basic Medicine,undefined
[9] Chinese Academy of Medical Sciences Peking Union Medical College 5,undefined
[10] Leibniz Institute for Age Research – Fritz Lipmann Institute e.V.,undefined
[11] Biology and Pharmacy Faculty,undefined
[12] Friedrich-Schiller-University,undefined
[13] Cancer and Stem Cell Biology Program,undefined
[14] Duke-NUS Graduate Medical School,undefined
[15] Duke-NUS Graduate Medical School,undefined
[16] National University of Singapore,undefined
来源
Cell Death & Differentiation | 2011年 / 18卷
关键词
ER-stress; p53; phosphorylation; protein stability; S312;
D O I
暂无
中图分类号
学科分类号
摘要
Cellular stimulation results in phosphorylation of the tumor suppressor p53 on multiple residues, though the functional relevance is not always clear. It is noteworthy that the serine (S) 315 residue is unique, as it has been suggested to be phosphorylated not only by genotoxic signals, but also during cell-cycle progression and by endoplasmic-reticulum stress. However, in vitro data have been conflicting as phosphorylation at this site was shown to both positively and negatively regulate p53 functions. We have thus generated knock-in mice expressing an unphosphorylable S312 (equivalent to human S315), by substitution with an alanine (A) residue, to clarify the conflicting observations and to evaluate its functional relevance in vivo. Born at Mendelian ratios, the p53S312A/S312A mice show no anomalies during development and adulthood. p53 activation, stability, localization and ability to induce apoptosis, cell-cycle arrest and prevent centrosome amplification are not compromised in p53S312A/S312A cells. p53S312A/S312A mice are unable to rescue mdm2−/− lethality, and tumorigenesis – both spontaneous and irradiation/oncogene-induced – is not accentuated. Taken together, the results show that the S312 phosphorylation site is not in itself necessary for efficient p53 function, and advocates the possibility that it is neither relevant in the mouse context nor important for p53 functions in vivo.
引用
收藏
页码:214 / 221
页数:7
相关论文
共 50 条
  • [41] Effects of adenoviral wild-type p53 gene transfer in p53 -mutated lymphoma cells
    Peter Buttgereit
    Frank Schakowski
    Angela Märten
    Karsten Brand
    Sabine Renoth
    Carsten Ziske
    Björn Schöttker
    Oliver Ebert
    Roland Schroers
    Ingo GH Schmidt-Wolf
    Cancer Gene Therapy, 2001, 8 : 430 - 439
  • [42] Interaction of p53 with the CCT Complex Promotes Protein Folding and Wild-Type p53 Activity
    Trinidad, Antonio Garcia
    Muller, Patricia A. J.
    Cuellar, Jorge
    Klejnot, Marta
    Nobis, Max
    Maria Valpuesta, Jose
    Vousden, Karen H.
    MOLECULAR CELL, 2013, 50 (06) : 805 - 817
  • [43] Enhanced apoptotic activity of a p53 variant in tumors resistant to wild-type p53 treatment
    Atencio, IA
    Avanzini, JB
    Johnson, D
    Neuteboom, S
    Vaillancourt, MT
    Nielsen, LL
    Hajian, G
    Sutjipto, S
    Sugarman, BJ
    Philopena, J
    McAllister, DL
    Beltran, JC
    Nodelman, M
    Ramachandra, M
    Wills, KN
    MOLECULAR THERAPY, 2001, 4 (01) : 5 - 12
  • [44] EQUAL TRANSCRIPTION OF WILD-TYPE AND MUTANT P53 USING BICISTRONIC VECTORS RESULTS IN THE WILD-TYPE PHENOTYPE
    FREBOURG, T
    SADELAIN, M
    NG, YS
    KASSEL, J
    FRIEND, SH
    CANCER RESEARCH, 1994, 54 (04) : 878 - 881
  • [45] Sensitization of rat glioblastoma multiforme to cisplatin in vivo following restoration of wild-type p53 function
    Dorigo, O
    Turla, ST
    Lebedeva, S
    Gjerset, RA
    JOURNAL OF NEUROSURGERY, 1998, 88 (03) : 535 - 540
  • [46] EFFECTS OF RESTORATION OF WILD-TYPE P53 EXPRESSION IN MALIGNANT KERATINOCYTES
    COURTOIS, SJ
    DEGREEF, H
    WOODWORTH, CD
    GARMYN, M
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1995, 105 (03) : 459 - 459
  • [47] Hyperubiquitylation of wild-type p53 contributes to cytoplasmic sequestration in neuroblastoma
    K Becker
    N D Marchenko
    M Maurice
    U M Moll
    Cell Death & Differentiation, 2007, 14 : 1350 - 1360
  • [48] Wild-type p53 activates SAP expression in lymphoid cells
    N Nagy
    M Takahara
    J Nishikawa
    J C Bourdon
    L L Kis
    G Klein
    E Klein
    Oncogene, 2004, 23 : 8563 - 8570
  • [49] Targeting Mdmx to treat breast cancers with wild-type p53
    S Haupt
    D Buckley
    J-MB Pang
    J Panimaya
    P J Paul
    C Gamell
    E A Takano
    Y Ying Lee
    S Hiddingh
    T-M Rogers
    A F A S Teunisse
    M J Herold
    J-C Marine
    S B Fox
    A Jochemsen
    Y Haupt
    Cell Death & Disease, 2015, 6 : e1821 - e1821
  • [50] REGULATION OF THE STRUCTURE AND FUNCTION OF WILD-TYPE AND MUTANT FORMS OF P53
    BARGONETTI, J
    CHEN, XB
    FARMER, G
    FRIEDLANDER, P
    JAYARAMAN, L
    MANFREDI, J
    MILLER, S
    WANG, Y
    PRIVES, C
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, : 162 - 162